Proteomics Market Set to Soar with Anticipated CAGR of 13.68% from 2023-2035 - ResearchAndMarkets.com

The "Global Proteomics Market Outlook 2022-2035" report has been added to ResearchAndMarkets.com's offering.

The global proteomics market is on a rapid growth trajectory and is expected to witness a significant compound annual growth rate (CAGR) of 13.68% from 2023 to 2035. According to a recently published industry report, the market is projected to expand from a valuation of USD 27 billion in 2022 to USD 144 billion by 2035.

This upsurge is buoyed by the increasing adoption of personalized medicine, a rising prevalence of cancer, and enhancements in product performance. The proteomics field is making strides in diagnostics and the development of tailored therapeutic approaches, reflecting the broader trend of individualized patient care.

Significant Growth within the Proteomics Reagents Segment Predicted

The report’s detailed market segmentation analysis reveals that the reagents segment is poised to achieve the largest revenue growth within the industry. By the close of 2035, reagents are expected to generate an astounding USD 97 billion, a significant climb from USD 19 billion in 2022. Immunoassay reagents, known for their stability and high sensitivity crucial for early disease diagnosis, are central to this expected growth.

Regional Insights Highlight North America's Dominance in Proteomics Market

From a regional standpoint, North America continues to dominate the global proteomics market, with substantial revenue growth from USD 11 billion in 2022 to an anticipated USD 62 billion by 2035. The region's robust market performance aligns with a pattern of new product introductions and enhancements in portfolio offerings.

Leading Industry Players Spearheading Market Advancement

An array of eminent industry leaders are at the forefront of this burgeoning market. These key players are instrumental in driving innovation and technological advancements in proteomics, impacting sectors such as drug discovery, diagnostic solutions, and therapeutic developments.

The extensive report on the global proteomics market offers insights that could catalyze strategic decisions and investments by stakeholders in the sector. As the industry progresses with these transformative developments, the report serves as a crucial resource for unfolding the proteomics landscape over the next decade.

The global expansion of the proteomics market presents a compelling narrative of innovation and growth. With the actionable intelligence provided by this comprehensive report, market participants can navigate the transformative journey of proteomics with informed precision.

Companies Mentioned

• Bio-Rad Laboratories Inc.
• Merck KGaA
• Agilent Technologies Inc.
• Bruker Corporation
• Luminex Corporation
• QIAGEN N.V.
• PerkinElmer Inc.
• Waters Corporation
• Biognosys
• HORIBA Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/3cnmp

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240322331200/en/